An interventional study of BAND Connect's VirtuaCare™ platform and Standard of Care Physical Therapy in Shoulder Injuries, sponsored by University of Cincinnati. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by University of Cincinnati · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Shoulder Injuries with a site in United States — 14 open to participants now, 18 under way, none of them phase 3. Shoulder Injuries · United States.
Among the 39 studies in Shoulder Injuries with a site in United States, this one is the 12th largest by enrollment of the 26 interventional ones that give a count, is one of 5 that started in 2022, is one of 20 with no phase, and was the 30th registered.
118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.
Browse Shoulder Injuries studies →14 of the 39 studies in Shoulder Injuries with a site in United States are open now. Recruiting first, the newest first:
Cedars-Sinai Medical Center · Sites in United States
Ages 18+
Stryker Endoscopy · Sites in United States
Ages 18+
Stanford University · Sites in United States
Ages 18+
University of Maryland, Baltimore · Sites in United States
Ages 18–95 · Healthy volunteers
Duke University · Sites in United States
Ages 18–80
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 17 Shoulder Injuries studies recruiting now, 8 (47%) set no upper age limit and 6 (35%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 5 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 77 is above the median of 55 across 69 interventional studies indexed under Shoulder Injuries.
Median enrollment 64 across the 26 interventional studies, 59 across the 13 observational. Of the 20 that completed or were terminated, 5 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 39 have an industry lead sponsor. The 10 most frequent:
University of Cincinnati is the lead sponsor of 324 studies on the registry; 42 are open to participants now.
Of its 24 completed or terminated interventional studies of FDA-regulated products, 15 (63%) have results posted.
University of Cincinnati has 1 study filed under Shoulder Injuries — fewer than ten, so there is no comparison to draw.
7 of the studies in Shoulder Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06016257Cedars-Sinai Medical CenterUsing VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study | 2026-12-31 |
| NCT04109638Stanford UniversityPulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery | 2027-02 |
| NCT05344898University of Maryland, BaltimoreSubscap Reverse Shoulder Arthroplasty | 2027-05-15 |
| NCT02600910The University of Texas Medical Branch, GalvestonNatural History of Shoulder Pathology in Manual Wheelchair Users | 2027-06 |
| NCT06501859University of UtahRehabilitation With the Shoulder Pacemaker | 2027-07 |
Add all 7 to your calendar (.ics) → With an account.
Among the 39 studies in Shoulder Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to enhance at-home therapy by introducing a new device called the BAND Connect's VirtuaCare™ platform. The study aims to determine whether patients can improve their adherence to at-home exercises using this device. Currently, research indicates that only 35% of patients undergoing physical therapy treatment fully comply with their prescribed plans of care, often neglecting their at-home exercises. To address this issue, a set of smart exercise tools called VirtuaCare™ has been developed. This platform provides patients with instructions on performing at-home exercises and offers real-time biofeedback to help them adjust their form if necessary. The study seeks to evaluate the effectiveness of BAND CVCP in assisting patients and improving their overall success with at-home therapy.
This study aims to compare the effectiveness of the BAND CVCP device with the standard physical therapy regimens provided by UC Health Orthopaedic Surgery. Participants undergoing shoulder surgeries performed by Dr. Brian Grawe will be randomly assigned to one of two groups. Group 1 will utilize the BAND CVCP both in the clinic and at home as a supplement to their treatment protocols. Group 2 will receive standard physical therapy without the BAND CVCP.
In Group 1, participants will be given access to the BAND CVCP and necessary materials during their first physical therapy appointment. The physical therapist will guide them through exercises using the device, recording their actions and providing real-time feedback. The BAND CVCP app on their provided Android phone will offer instructions for each exercise, eliminating the need to memorize the routine.
During clinic visits, Group 1 participants' progress will be reviewed using the BAND CVCP participant report. The report will display information such as completed exercises, form, pace, range of motion, and exertion, which is measured by sensors in the BAND CVCP handles. The therapist will help participants understand any corrections needed for their at-home exercises and make adjustments to their rehabilitation plan accordingly.
Both Group 1 and Group 2 participants will complete patient report outcomes at different intervals, including pre-operative scores, weekly visual analog scale assessments, and monthly assessments such as the Upper Extremity Functional Index (UEFI) or Quick Disabilities of Arm, Shoulder, and Hand (QuickDASH). Group 1 participants will complete these forms using the BAND CVCP's phone application, while Group 2 participants will use paper copies at the clinic.
Additional assessments will be conducted at the 3-month, 6-month, and discharge from care visits, which include the ASES, SST, and EQ-5D-5L forms. Group 1 participants will complete these assessments on the BAND CVCP's phone application, while Group 2 participants will use paper copies at the clinic.
This study aims to evaluate the effectiveness of the BAND CVCP device compared to standard physical therapy regimens and track participant rehabilitation outcomes throughout the process.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group 1 will be using the BAND CVCP both in the clinic and at home to supplement the treatment protocols used in the clinic today.
Other: BAND Connect's VirtuaCare™ platform
Group 2 will receive standard-of-care physical therapy without the use of the BAND CVCP.
Other: Standard of Care Physical Therapy
Band Connect provides a medical-grade and condition-specific platform that augments the clinician workflow by extending the in-clinic MSK rehabilitation experience into the patient's home - leading to higher quality personalized treatment and increased adherence with enhanced economics and reimbursement for the clinic.
Standard of care physical therapy without the use of the BAND CVCP
Number of Visits
Number of visits with physical therapist
Time frame: 12 weeks
Plan to share: No
Ran from Jul 2022 to primary completion in Apr 2026, 45 months.
Of 38 non-industry interventional studies with no phase under Shoulder Injuries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's 45 months is above that.
Counting every sponsor, half of 43 studies reached it within 15 months; a quarter within 7 and three quarters within 45.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: primary completion Jan 2027 → Apr 2026 and completion Jul 2027 → Apr 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.